Agilent (NYSE: A) director trims stake with 1,600-share stock sale

Rhea-AI Filing Summary

Agilent Technologies director Mikael Dolsten sold 1,600 shares of common stock in an open-market transaction at $135.42 per share. After this sale, he directly holds 5,548.385 shares. This balance includes 10.175 shares acquired through Agilent’s dividend reinvestment plan, which he has elected to defer.

Insider Trade Summary

Net Seller: 1,600 shares ($216,672)

Net Sell 1 txn

Insider Dolsten Mikael

Role null

Sold 1,600 shs ($217K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,600	$135.42	$217K

Holdings After Transaction: Common Stock — 5,548.385 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 1,600 shares Sale price: $135.42 per share Shares held after transaction: 5,548.385 shares +1 more

4 metrics

Shares sold 1,600 shares Open-market sale on May 29, 2026

Sale price $135.42 per share Open-market sale of common stock

Shares held after transaction 5,548.385 shares Direct ownership following sale

Dividend reinvestment shares 10.175 shares Acquired under dividend reinvestment plan and deferred

Key Terms

open-market sale, Rule 16a-11, dividend reinvestment plan

3 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Rule 16a-11 regulatory

"transactions exempt under Rule 16a-11"

dividend reinvestment plan financial

"acquired under the Agilent Technologies, Inc. dividend reinvestment plan"

A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dolsten Mikael

(Last) (First) (Middle)

5301 STEVENS CREEK BLVD.

(Street)

SANTA CLARA CALIFORNIA 95051

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/29/2026		S		1,600	D	$135.42	5,548.385(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 10.175 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan in transactions exempt under Rule 16a-11. The reporting person has elected to defer these shares of common stock.

	/s/ Shirley Qin, attorney-in-fact for Mr. Dolsten	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Agilent (A) director Mikael Dolsten report?

Mikael Dolsten reported an open-market sale of 1,600 shares of Agilent common stock. The sale occurred on May 29, 2026 at a price of $135.42 per share, according to the Form 4 insider trading disclosure.

At what price did Mikael Dolsten sell Agilent (A) shares?

He sold the 1,600 Agilent shares at $135.42 per share. This price reflects the average sale price reported for the open-market transaction disclosed in the Form 4 filing for May 29, 2026.

How many Agilent (A) shares does Mikael Dolsten hold after the sale?

After the transaction, Mikael Dolsten directly holds 5,548.385 shares of Agilent common stock. This total includes 10.175 shares acquired under Agilent’s dividend reinvestment plan, which he has elected to defer.

What does the Form 4 say about Agilent (A) dividend reinvestment shares?

The filing notes that 10.175 of Dolsten’s Agilent shares were acquired through the company’s dividend reinvestment plan. These transactions were exempt under Rule 16a-11, and he has elected to defer these particular shares of common stock.

Was the Agilent (A) director’s trade a purchase or a sale?

The Form 4 reports a sale transaction, coded "S" for an open-market or private sale. Dolsten disposed of 1,600 shares of Agilent common stock rather than acquiring additional shares in this particular filing.